Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Up 18,060.0% in February

Therapeutic Solutions International, Inc. (OTCMKTS:TSOIGet Free Report) was the recipient of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 181,600 shares, an increase of 18,060.0% from the January 31st total of 1,000 shares. Based on an average daily volume of 50,287,400 shares, the days-to-cover ratio is presently 0.0 days.

Therapeutic Solutions International Stock Performance

Therapeutic Solutions International stock opened at $0.00 on Friday. Therapeutic Solutions International has a 12 month low of $0.00 and a 12 month high of $0.00.

Therapeutic Solutions International Company Profile

(Get Free Report)

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.

Featured Articles

Receive News & Ratings for Therapeutic Solutions International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Therapeutic Solutions International and related companies with MarketBeat.com's FREE daily email newsletter.